DAMIAN, SILVIA

DAMIAN, SILVIA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.005 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples 2022 Capone I.Verderio P.Busico A.Monti V.Duca M.Damian S.Lorenzini D.Vingiani A.Agnelli L.Pruneri G. + Article (author) -
Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study 2022 Corradini, PaoloMantovani, AlbertoMarasco, VincenzoDamian, SilviaRescigno, Maria + Article (author) -
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model 2022 Azzollini, JacopoVingiani, AndreaAgnelli, LucaRosina, EricaDucceschi, MonikaNiger, MonicaDamian, Silviade Braud, FilippoPruneri, Giancarlo + Article (author) -
Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors 2021 Pietrantonio, FilippoCorti, FrancescaInfante, GabrieleCurigliano, GiuseppeAmbrosini, MargheritaDamian, Silvia + Article (author) -
Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study 2019 Mariani GGalli GCavalieri SDamian SDuca Mde Braud F + Article (author) -
Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib : combined results from two phase I trials (ALKA-372-001 and STARTRK-1) 2017 S. SienaG. CereaG. MarrapeseA. Sartore-BianchiA. VanzulliS. DamianM. DucaF. G. De Braud + Article (author) -
Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? : Analysis of a phase II trial 2013 S. DamianE. De BenedictisF. AgustoniF. RicchiniF. De Braud + Article (author) -